Trident Lifeline Ltd. Announces Strategic Alliance with NIPER-A for Technology Transfer of Vorinostat

Trident Lifeline Limited has entered into a strategic alliance with National Institutes of Pharmaceutical Education and Research- Ahmedabad (NIPER-A) for the technology transfer of Vorinostat, a crucial medication for treating Cutaneous T-Cell Lymphoma (CTCL). This collaboration aims to revolutionize the treatment landscape for CTCL patients by providing access to a high-quality, domestically produced Vorinostat. Trident Lifeline Ltd. will scale up the production of Vorinostat and introduce it to the Indian market by leveraging NIPER Ahmedabad's expertise. The company also aims to provide Vorinostat free of charge to economically disadvantaged patients, embracing the spirit of the Make-in-India initiative.